International Stem Cell (OTCMKTS:ISCO) Shares Pass Above 200-Day Moving Average – What’s Next?

International Stem Cell Corp. (OTCMKTS:ISCO)’s stock price crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.22 and traded as high as $0.35. International Stem Cell shares last traded at $0.33, with a volume of 8,300 shares changing hands.

International Stem Cell Stock Down 1.2%

The firm’s 50 day simple moving average is $0.33 and its 200 day simple moving average is $0.22. The company has a market capitalization of $2.61 million and a PE ratio of -4.08.

International Stem Cell (OTCMKTS:ISCO) last announced its earnings results on Thursday, August 13th. The biotechnology company reported ($0.01) earnings per share for the quarter. The firm had revenue of $2.67 million for the quarter.

International Stem Cell Company Profile

International Stem Cell Corporation (OTCMKTS:ISCO) is a biotechnology company focused on the development and commercialization of human parthenogenetic stem cells (hpSC) for therapeutic and research applications. Parthenogenetic stem cells are derived from unfertilized human eggs and offer a scalable, ethically noncontroversial source of pluripotent cells. ISCO’s proprietary hpSC lines can be directed to differentiate into a wide variety of cell types, enabling preclinical programs in areas such as neurodegenerative disease, liver disease, diabetes and corneal regeneration.

In addition to its therapeutic pipeline, International Stem Cell maintains a research products division that supplies hpSC lines, differentiated cell populations and media formulations to academic institutions, biotechnology companies and contract research organizations.